Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,056.55
-13.85 (-1.29%)
At close: May 29, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 129.55 billion as of June 1, 2026. Its market cap has decreased by -5.30% in one year.
Market Cap
129.55B
Enterprise Value
122.29B
Revenue
25.52B
Ranking
n/a
PE Ratio
22.95
Stock Price
1,056.55
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 129.55B, an increase of 41.26%. That is a compound annual growth rate of 7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 129.55B | 15.21% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 218.98B |
| Shilpa Medicare | 97.43B |
| Suven Life Sciences | 73.67B |
| Gujarat Themis Biosyn | 44.03B |
| IOL Chemicals and Pharmaceuticals | 37.77B |
| Sai Parenteral's | 21.47B |
| NGL Fine-Chem | 17.22B |
| Bajaj HealthCare | 10.15B |